Article | September 1, 2016

GSK President Of Vaccines Weighs In On Challenges Presented By Ebola And Zika

Source: Life Science Leader
Rob Wright author page

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Cutting Room Floor

Following Luc Debruyne’s participation in an educational session at this year’s BIO International Convention, the president of GSK Vaccines sat down with me to shares his insights on the world of vaccines. During our conversation, (much of which was captured in the September 2016 feature article in Life Science Leader magazine), I asked Debruyne about some of the challenges faced by vaccine developers when it comes to viruses like Ebola and Zika.